GO:0061870 positive regulation of hepatic stellate cell migration: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061870 describes any process that increases the frequency, rate or extent of hepatic stellate cell (HSC) migration, a central event in liver fibrosis and hepatocellular carcinoma (HCC) progression.
• HSC migration is positively regulated by extracellular matrix proteins such as tenascin-C and laminin-5, which promote HSC motility and collagen production.
• TGF-beta1 signaling drives HSC activation and migration through feedback loops involving CD147, while FUT8 upregulation inhibits TGF-beta1-induced HSC activation.
• Adiponectin negatively regulates HSC migration by promoting TIMP-1 secretion, highlighting a protective endocrine axis.
• CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression, linking immune-microenvironment crosstalk to HSC behavior.
• Spatial transcriptomic-metabolic profiling of HCC reveals tumor capsule and microvascular invasion features that involve HSC-rich niches.
Description
Hepatic stellate cells (HSCs) are resident mesenchymal cells of the liver that, upon activation, acquire a myofibroblast-like phenotype and migrate toward sites of injury. The Gene Ontology term GO:0061870, positive regulation of hepatic stellate cell migration, captures the biological processes that increase the frequency, rate or extent of HSC migration. This term is critical for understanding liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) progression, because HSC motility directly influences extracellular matrix remodeling and tumor microenvironment crosstalk. Researchers studying chronic liver disease use GO:0061870 to annotate genes and pathways that drive HSC recruitment to damaged tissue. For example, tenascin-C and laminin-5 are extracellular matrix proteins that promote HSC migration and collagen production, thereby amplifying fibrogenesis. Conversely, adiponectin reduces HSC migration by promoting TIMP-1 secretion, illustrating negative regulation of this process. The term also intersects with immune cell interactions: CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression, demonstrating that positive regulation of HSC migration is embedded in a complex cellular network. Understanding GO:0061870 therefore requires integrating signaling pathways, matrix biology, and immune-microenvironment interactions.
positive regulation of hepatic stellate cell migration At A Glance
| GO ID | GO:0061870 |
|---|---|
| GO term | positive regulation of hepatic stellate cell migration |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increases the frequency, rate or extent of hepatic stellate cell migration |
| Related processes | HSC activation, liver fibrosis, extracellular matrix remodeling, HCC progression |
| Key positive regulators | Tenascin-C, laminin-5, TGF-beta1-CD147 loop, CX3CR1+ macrophages |
| Key negative regulator | Adiponectin via TIMP-1 secretion |
| Disease relevance | Liver fibrosis, cirrhosis, hepatocellular carcinoma |
What Is GO:0061870?
GO:0061870 is defined by QuickGO as any process that increases the frequency, rate or extent of hepatic stellate cell migration. In practical terms, it encompasses molecular signals, extracellular matrix cues, and cellular interactions that enhance the movement of HSCs from one location to another within the liver. This biological process is a positive regulatory counterpart to negative regulation of HSC migration and is distinct from HSC activation, proliferation, or contraction, although these processes are often coordinated during liver injury.
Why Is positive regulation of hepatic stellate cell migration Important in Cell Biology?
Positive regulation of hepatic stellate cell migration is a pivotal driver of liver fibrosis and HCC progression. During chronic liver injury, HSCs migrate to damaged areas and produce excessive extracellular matrix, leading to scar formation and organ dysfunction. This process also facilitates tumor-promoting microenvironments, as HSCs can stimulate HCC cell migration via laminin-5 production and interact with immune cells to suppress antitumor immunity. Targeting the positive regulation of HSC migration may therefore offer therapeutic strategies to limit fibrosis and halt cancer progression.
• Drives HSC recruitment to sites of liver injury, initiating fibrotic remodeling.
• Promotes extracellular matrix deposition and collagen production, contributing to cirrhosis.
• Facilitates HCC progression by stimulating cancer cell migration and immune evasion.
• Serves as a therapeutic target: inhibiting HSC migration may reduce fibrosis.
• Involves crosstalk with immune cells such as CX3CR1+ macrophages.
• Regulated by TGF-beta1 signaling and CD147 feedback loops.
• Modulated by metabolic factors like adiponectin and glutaminolysis.
• Relevant to spatial tumor features such as capsule and microvascular invasion.
• Provides biomarkers for liver disease progression and treatment response.
• Enables mechanistic studies using CRISPR screens and knockout models.
What Happens During positive regulation of hepatic stellate cell migration?
Initiation by Extracellular Matrix Cues
In simple terms: The process starts when matrix proteins around the liver cell send 'move' signals.
Positive regulation of HSC migration is initiated by extracellular matrix components such as tenascin-C and laminin-5. Tenascin-C promotes HSC migration and type I collagen production, thereby enhancing fibrogenic responses. Similarly, HSCs stimulate HCC cell migration via laminin-5 production, indicating that matrix-derived signals can amplify migratory behavior in both HSCs and neighboring tumor cells. These cues activate integrin-mediated signaling and cytoskeletal reorganization, leading to directed cell movement.
TGF-beta1 and CD147 Feedback Loop
In simple terms: A growth factor called TGF-beta1 creates a self-reinforcing loop that keeps HSCs moving and activated.
TGF-beta1 is a master regulator of HSC activation and migration. Activation of a TGF-beta1-CD147 positive feedback loop in HSCs promotes liver fibrosis, sustaining migratory and fibrogenic phenotypes. This loop involves CD147 (basigin) and downstream signaling that reinforces TGF-beta1 production, creating a persistent pro-migratory state. FUT8 upregulation inhibits TGF-beta1-induced activation of HSCs, suggesting that glycosylation changes can modulate this pathway.
Immune Cell Crosstalk
In simple terms: Immune cells in the liver can tell stellate cells to move, helping tumors grow.
CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression, demonstrating that immune cells can positively regulate HSC migration and function. This crosstalk creates a tumor-permissive microenvironment where HSC motility contributes to immune evasion and cancer progression. Spatial transcriptomic-metabolic studies of HCC further reveal distinct tumor foci and capsule features that may involve HSC-rich niches.
Metabolic and Pharmacological Modulation
In simple terms: Drugs and metabolic changes can either boost or block stellate cell movement.
Adiponectin reduces HSC migration by promoting TIMP-1 secretion, providing a negative regulatory mechanism that opposes positive regulation. Cordycepin alleviates hepatic fibrosis by inhibiting glutaminolysis and promoting HSC senescence, indirectly limiting migratory capacity. These examples show that positive regulation of HSC migration is balanced by metabolic and pharmacological inputs, offering intervention points for fibrosis therapy.
Key Genes Involved in GO:0061870 positive regulation of hepatic stellate cell migration
The following genes and proteins have been experimentally linked to positive regulation of hepatic stellate cell migration.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNC | Tenascin-C promotes HSC migration and type I collagen production | Matrix-derived positive regulator; target for fibrosis |
| LAMA5 | Laminin-5 production by HSCs stimulates HCC cell migration | Links HSC motility to tumor progression |
| TGFB1 | Master cytokine driving HSC activation and migration | Central to TGF-beta1-CD147 feedback loop |
| CD147 (BSG) | Forms positive feedback loop with TGF-beta1 in HSCs | Promotes liver fibrosis and HSC motility |
| FUT8 | Upregulation inhibits TGF-beta1-induced HSC activation | Glycosylation-dependent modulation of HSC behavior |
| ADIPOQ | Adiponectin reduces HSC migration via TIMP-1 secretion | Negative regulator of HSC migration |
| TIMP1 | Mediates adiponectin-induced inhibition of HSC migration | Protective factor against fibrosis |
| CX3CR1 | Expressed on macrophages interacting with HSCs | Immune crosstalk promoting HCC |
| COL1A1 | Type I collagen produced downstream of HSC migration | Fibrosis marker and effector |
| ACTA2 | Alpha-smooth muscle actin, marker of activated HSCs | Readout of HSC activation and migration |
| GLS | Glutaminolysis enzyme; inhibition promotes HSC senescence | Metabolic target for fibrosis |
| CD8A | T-cell marker suppressed by CX3CR1+ macrophage-HSC crosstalk | Immune evasion in HCC |
| MMP2 | Matrix metalloproteinase involved in ECM remodeling | Associated with HSC migration and invasion |
| MMP9 | Matrix metalloproteinase linked to HSC motility | Potential mediator of HSC migration |
| ITGB1 | Integrin beta-1 mediates matrix adhesion during migration | Cytoskeletal signaling in HSC motility |
| ITGAV | Integrin alpha-V binds matrix proteins to promote migration | Potential therapeutic target |
| PTK2 (FAK) | Focal adhesion kinase downstream of integrin signaling | Regulates HSC migration machinery |
| RHOA | Small GTPase controlling cytoskeletal dynamics | Essential for HSC motility |
How Is positive regulation of hepatic stellate cell migration Regulated?
Positive regulation of hepatic stellate cell migration is controlled by a balance of pro-migratory and anti-migratory signals. TGF-beta1 and its CD147 feedback loop sustain HSC activation and motility, while FUT8 upregulation inhibits TGF-beta1-induced activation. Adiponectin counteracts migration by promoting TIMP-1 secretion. Metabolic pathways such as glutaminolysis influence HSC senescence and indirectly migration. Immune cells, including CX3CR1+ macrophages, can positively regulate HSC behavior in the tumor microenvironment. These layers of regulation provide multiple nodes for therapeutic intervention.
positive regulation of hepatic stellate cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNC | Liver fibrosis | Tnc knockout mice with CCl4-induced fibrosis |
| TGFB1 | Liver fibrosis, HCC | TGF-beta1 transgenic or knockout models |
| CD147 (BSG) | Liver fibrosis | CD147 knockout HSC cell lines |
| ADIPOQ | Liver fibrosis protection | Adiponectin knockout mice |
| CX3CR1 | HCC immune evasion | CX3CR1 knockout mouse HCC models |
Liver Fibrosis and Cirrhosis
Positive regulation of HSC migration is a core driver of liver fibrosis. Tenascin-C promotes HSC migration and type I collagen production, leading to excessive matrix deposition. The TGF-beta1-CD147 feedback loop further amplifies fibrogenesis. Adiponectin-mediated inhibition of HSC migration via TIMP-1 highlights a protective axis that is lost in fibrosis. Targeting these pathways may reduce scar formation.
Hepatocellular Carcinoma (HCC)
HSCs stimulate HCC cell migration via laminin-5 production, linking HSC motility to tumor invasion. CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression, creating an immunosuppressive microenvironment. Spatial transcriptomic-metabolic profiling of HCC reveals tumor capsule and microvascular invasion features that may involve HSC-rich niches. Thus, positive regulation of HSC migration contributes to HCC progression.
Therapeutic Modulation
Cordycepin alleviates hepatic fibrosis by inhibiting glutaminolysis and promoting HSC senescence, indirectly reducing migratory capacity. FUT8 upregulation inhibits TGF-beta1-induced HSC activation, suggesting glycosylation-based interventions. These findings support the development of drugs that block positive regulation of HSC migration.
From positive regulation of hepatic stellate cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TNC promote HSC migration? | TNC knockout HSC cell line (CRISPR KO) |
| Does FUT8 inhibit TGF-beta1-induced activation? | FUT8 overexpression in HSCs |
| Does CD147 feedback loop drive fibrosis? | CD147 point mutation or knock-in HSCs |
| Does adiponectin reduce HSC migration? | ADIPOQ overexpression in HSCs |
| Does CX3CR1+ macrophage crosstalk promote HCC? | CX3CR1 knockout mouse HCC model |
| Does glutaminolysis inhibition induce HSC senescence? | GLS knockout or inhibitor-treated HSCs |
How to Study the positive regulation of hepatic stellate cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify regulators of HSC migration |
| Boyden chamber assay | Cell migration frequency and rate | Test pro-migratory factors |
| Wound-healing assay | Directional cell movement | Validate HSC migration modulation |
| Co-immunoprecipitation | Protein-protein interactions | Detect TGF-beta1-CD147 complexes |
| CRISPR knockout screen | Gene essentiality for migration | Discover novel positive regulators |
| Spatial transcriptomics | Tissue localization of gene expression | Map HSC niches in HCC |
| Senescence assay | HSC senescence induction | Evaluate glutaminolysis inhibition |
| Immunoblotting | Protein expression and activation | Measure ACTA2, COL1A1, TIMP-1 |
Transcriptomic Profiling
RNA-seq of HSCs under pro-migratory conditions can identify genes differentially expressed during positive regulation of migration. Spatial transcriptomic-metabolic profiling of HCC tissues has revealed tumor capsule and microvascular invasion features that may involve HSC migration. These approaches help annotate GO:0061870 with candidate regulators.
Migration Assays
Boyden chamber and wound-healing assays directly measure HSC migration frequency and rate. Treatment with tenascin-C or laminin-5 can stimulate migration, while adiponectin or TIMP-1 can inhibit it. These assays are essential for validating positive regulation.
Protein-Protein Interaction Studies
Co-immunoprecipitation and proximity ligation can detect TGF-beta1-CD147 interactions and downstream signaling complexes. Such methods reveal how feedback loops sustain HSC motility.
CRISPR Screening
Genome-wide CRISPR knockout screens in HSCs can identify genes whose loss reduces migration. Hits can be validated with focused libraries targeting matrix, integrin, and TGF-beta pathways.
How CRISPR Can Be Used to Study GO:0061870 positive regulation of hepatic stellate cell migration
Knockout
CRISPR knockout of genes such as TNC, CD147, or CX3CR1 in HSC lines or mouse models can abolish positive regulation of HSC migration, providing causal evidence. For example, TNC knockout reduces HSC migration and collagen production.
Point Mutation
Introducing point mutations in TGFB1 or CD147 can disrupt the feedback loop and reduce HSC motility. Such models help dissect specific signaling residues required for positive regulation.
Knock-in
Knock-in of tagged versions of CD147 or TGF-beta1 allows live-cell imaging of protein dynamics during HSC migration. This approach reveals real-time localization and interaction kinetics.
Overexpression
Overexpression of FUT8 or ADIPOQ can inhibit HSC migration, serving as gain-of-function models for negative regulation. Conversely, overexpression of TNC or laminin-5 enhances migration.
How EDITGENE Supports positive regulation of hepatic stellate cell migration Research
Researchers studying positive regulation of hepatic stellate cell migration-related genes often need to determine whether a candidate gene is causally involved in HSC motility, matrix remodeling, or immune crosstalk. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous functional validation of GO:0061870 regulators.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of hepatic stellate cell migration research.
Frequently Asked Questions About positive regulation of hepatic stellate cell migration
What is GO:0061870?
GO:0061870 is the Gene Ontology term for positive regulation of hepatic stellate cell migration, defined as any process that increases the frequency, rate or extent of hepatic stellate cell migration.
What genes are involved in positive regulation of hepatic stellate cell migration?
Key genes include TNC, LAMA5, TGFB1, CD147, FUT8, ADIPOQ, TIMP1, and CX3CR1, as shown in fibrosis and HCC studies.
How does tenascin-C affect hepatic stellate cell migration?
Tenascin-C promotes HSC migration and type I collagen production, enhancing fibrogenic responses.
Does adiponectin inhibit hepatic stellate cell migration?
Yes, adiponectin reduces HSC migration by promoting TIMP-1 secretion.
What is the role of TGF-beta1 in HSC migration?
TGF-beta1 drives HSC activation and migration through a positive feedback loop involving CD147.
How do CX3CR1+ macrophages influence HSC migration?
CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression, linking immune crosstalk to HSC behavior.
Can CRISPR be used to study HSC migration?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can validate genes involved in positive regulation of HSC migration.
What diseases are associated with positive regulation of HSC migration?
Liver fibrosis, cirrhosis, and hepatocellular carcinoma are major diseases linked to this process.
How is FUT8 involved in HSC activation?
Upregulation of FUT8 inhibits TGF-beta1-induced activation of hepatic stellate cells during liver fibrogenesis.
What methods measure HSC migration?
Boyden chamber, wound-healing assays, RNA-seq, and CRISPR screens are commonly used to measure and study HSC migration.
Conclusion
GO:0061870, positive regulation of hepatic stellate cell migration, is a critical biological process in liver fibrosis and HCC. Key regulators such as tenascin-C, laminin-5, TGF-beta1-CD147 loop, and CX3CR1+ macrophages promote HSC motility, while adiponectin and FUT8 provide inhibitory control. Understanding these mechanisms offers therapeutic opportunities. EDITGENE supports researchers with advanced CRISPR models to dissect this process and accelerate drug discovery.
References
- 1. Jeong JM et al.. 2025. CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression.. Hepatology 82(3):655-668 PMID: 40833997
- 2. Ramezani-Moghadam M et al.. 2015. Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion.. J Biol Chem 290(9):5533-42 PMID: 25575598
- 3. Luo ZH et al.. 2026. Spatial transcriptomic-metabolic features of tumor foci and tumor capsule in microvascular invasion with hepatocellular carcinoma: A spatial multi-omics study.. PLoS Med 23(5):e1004703 PMID: 42139279
- 4. Kuang M et al.. 2021. Up-regulation of FUT8 inhibits TGF-β1-induced activation of hepatic stellate cells during liver fibrogenesis.. Glycoconj J 38(1):77-87 PMID: 33608773
- 5. Santamato A et al.. 2011. Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.. Clin Sci (Lond) 121(4):159-68 PMID: 21413933
- 6. Ma JC et al.. 2016. Tenascin-C promotes migration of hepatic stellate cells and production of type I collagen.. Biosci Biotechnol Biochem 80(8):1470-7 PMID: 27031437
- 7. Li HY et al.. 2015. Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis.. Sci Rep 5:16552 PMID: 26559755
- 8. Liang Z et al.. 2024. Cordycepin alleviates hepatic fibrosis in association with the inhibition of glutaminolysis to promote hepatic stellate cell senescence.. Int Immunopharmacol 132:111981 PMID: 38565039
